{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:49:03Z","timestamp":1780667343987,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD097775"],"award-info":[{"award-number":["R01HD097775"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019286","name":"Frontiers Clinical and Translational Science Institute, University of Kansas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010573","name":"University of Utah School of Medicine Center for Clinical and Translational Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejpb.2024.114261","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T03:05:42Z","timestamp":1710385542000},"page":"114261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Reducing hydrophobic drug adsorption in an in-vitro extracorporeal membrane oxygenation model"],"prefix":"10.1016","volume":"198","author":[{"given":"Nitish","family":"Khurana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamiya","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debika","family":"Ghatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6884-9464","authenticated-orcid":false,"given":"Jane","family":"Staples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0324-6673","authenticated-orcid":false,"given":"Oliver","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-9054","authenticated-orcid":false,"given":"Venkata","family":"Yellepeddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9333-9964","authenticated-orcid":false,"given":"Hamidreza","family":"Ghandehari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114261_b0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-200342050-00001","article-title":"Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates","volume":"42","author":"Buck","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ejpb.2024.114261_b0010","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.clinthera.2016.07.169","article-title":"Pharmacokinetics and dosing of anti-infective drugs in patients on Extracorporeal membrane oxygenation: a review of the current literature","volume":"38","author":"Sherwin","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.ejpb.2024.114261_b0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/FJC.0b013e318213aac2","article-title":"Pediatric cardiovascular drug dosing in critically ill children and extracorporeal membrane oxygenation","volume":"58","author":"Watt","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ejpb.2024.114261_b0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/clpt.2014.102","article-title":"Lack of drug dosing guidelines for critically ill patients receiving continuous renal replacement therapy","volume":"96","author":"Goldstein","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejpb.2024.114261_b0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/sdi.12203","article-title":"Antibiotic dosing in critically ill patients receiving CRRT: underdosing is overprevalent","volume":"27","author":"Lewis","year":"2014","journal-title":"Semin Dial"},{"key":"10.1016\/j.ejpb.2024.114261_b0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejpb.2006.06.005","article-title":"Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions","volume":"64","author":"Palmgr\u00e9n","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ejpb.2024.114261_b0035","first-page":"288","article-title":"Medication adsorption into contemporary extracorporeal membrane oxygenator circuits","volume":"19","author":"Harthan","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.ejpb.2024.114261_b0040","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1051\/ject\/200739234","article-title":"In vitro drug adsorption and plasma free hemoglobin levels associated with hollow fiber oxygenators in the extracorporeal life support (ECLS) circuit","volume":"39","author":"Preston","year":"2007","journal-title":"J Extra Corpor Technol"},{"key":"10.1016\/j.ejpb.2024.114261_b0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1051\/ject\/201042199","article-title":"Modified surface coatings and their effect on drug adsorption within the extracorporeal life support circuit","volume":"42","author":"Preston","year":"2010","journal-title":"J Extra Corpor Technol"},{"key":"10.1016\/j.ejpb.2024.114261_b0050","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0142-9612(00)00389-6","article-title":"Adsorption of xenobiotics to plastic tubing incorporated into dynamic in vitro systems used in pharmacological research\u2013limits and progress","volume":"22","author":"Unger","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2024.114261_b0055","first-page":"437","article-title":"Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation?","volume":"19","author":"Shekar","year":"2015","journal-title":"Illustrative Data from Ovine Models, Crit Care"},{"key":"10.1016\/j.ejpb.2024.114261_b0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13054-015-0891-z","article-title":"Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study","volume":"19","author":"Shekar","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.ejpb.2024.114261_b0065","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00134-010-2041-z","article-title":"Determinants of drug absorption in different ECMO circuits","volume":"36","author":"Wildschut","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ejpb.2024.114261_b0070","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1010-7940(00)00508-X","article-title":"Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface","volume":"18","author":"De Somer","year":"2000","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ejpb.2024.114261_b0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0003-4975(03)00338-2","article-title":"A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit","volume":"76","author":"Palatianos","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejpb.2024.114261_b0080","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1525-1594.2000.06615.x","article-title":"Biocompatibility of heparin-coated extracorporeal bypass circuits: new heparin bonded bioline system","volume":"24","author":"Tayama","year":"2000","journal-title":"Artificial Organs"},{"key":"10.1016\/j.ejpb.2024.114261_b0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MAT.0000000000000489","article-title":"Investigation of key circuit constituents affecting drug sequestration during Extracorporeal membrane oxygenation treatment","volume":"63","author":"Park","year":"2017","journal-title":"ASAIO J"},{"key":"10.1016\/j.ejpb.2024.114261_b0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00007691-199308000-00001","article-title":"Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs","volume":"15","author":"Dagan","year":"1993","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ejpb.2024.114261_b0095","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00134-007-0606-2","article-title":"Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment","volume":"33","author":"Mehta","year":"2007","journal-title":"Intensive Care Med"},{"issue":"Suppl 4","key":"10.1016\/j.ejpb.2024.114261_b0100","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1007\/PL00003783","article-title":"The recent development of propofol (DIPRIVAN)","volume":"26","author":"Thompson","year":"2000","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ejpb.2024.114261_b0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13054-015-0772-5","article-title":"Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood","volume":"19","author":"Lemaitre","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.ejpb.2024.114261_b0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/026765910001500104","article-title":"In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation","volume":"15","author":"Mulla","year":"2000","journal-title":"Perfusion"},{"key":"10.1016\/j.ejpb.2024.114261_b0115","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF03009997","article-title":"Propofol sequestration within the extracorporeal circuit","volume":"41","author":"Hynynen","year":"1994","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.ejpb.2024.114261_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i1.10","article-title":"Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers","volume":"19","author":"Kabanov","year":"2002","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.ejpb.2024.114261_b0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.ejpb.2024.114261_b0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1208\/s12248-023-00817-2","article-title":"Micellar encapsulation of propofol reduces its adsorption on Extracorporeal membrane oxygenator (ECMO) circuit","volume":"25","author":"Khurana","year":"2023","journal-title":"AAPS J"},{"key":"10.1016\/j.ejpb.2024.114261_b0135","article-title":"Vascular permeability in chronic rhinosinusitis enhances accumulation and retention of nanoscale pegylated liposomes","volume":"38","author":"Khurana","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2024.114261_b0140","unstructured":"https:\/\/www.cancer.gov\/nano\/research\/ncl\/protocols-capabilities\/ncl-method-ita-5.2.pdf. Accessed on 11\/28\/2023."},{"key":"10.1016\/j.ejpb.2024.114261_b0145","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s42114-021-00244-x","article-title":"Modification strategies to improve the membrane hemocompatibility in extracorporeal membrane oxygenator","volume":"4","author":"He","year":"2021","journal-title":"Adv Compos Hybrid Mater"},{"key":"10.1016\/j.ejpb.2024.114261_b0150","unstructured":"FDA, Guidance for Industry. Applications Covered by Section 505(b)(2), U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), October 1999 (1999)."},{"key":"10.1016\/j.ejpb.2024.114261_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27093042","article-title":"Solubility and permeability enhancement of oleanolic acid by solid dispersion in Poloxamers and \u03b3-CD","volume":"27","author":"De Stefani","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2024.114261_b0160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jlb.59.4.555","article-title":"Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3","volume":"59","author":"Schwende","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ejpb.2024.114261_b0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ejpb.2024.114261_b0170","doi-asserted-by":"crossref","first-page":"e8668","DOI":"10.1371\/journal.pone.0008668","article-title":"The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages","volume":"5","author":"Daigneault","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2024.114261_b0175","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejpb.2024.114261_b0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.ejpb.2024.114261_b0185","doi-asserted-by":"crossref","first-page":"e0178442","DOI":"10.1371\/journal.pone.0178442","article-title":"Increase in complement iC3b is associated with anti-inflammatory cytokine expression during late pregnancy in mice","volume":"12","author":"Nakamura","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2024.114261_b0190","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001712","article-title":"Complement controls the immune synapse and tumors control complement","volume":"8","author":"Herbert","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejpb.2024.114261_b0195","article-title":"Nanoparticle-induced complement activation: implications for cancer nanomedicine","volume":"11","author":"La-Beck","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejpb.2024.114261_b0200","doi-asserted-by":"crossref","first-page":"18594","DOI":"10.1021\/acsami.1c03284","article-title":"Understanding and Characterizing the drug sorption to PVC and PE materials","volume":"13","author":"Sahnoune","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ejpb.2024.114261_b0205","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1021\/acsapm.2c00532","article-title":"Drug Interactions with plasticized PVCs","volume":"4","author":"Sahnoune","year":"2022","journal-title":"ACS Applied Polymer Materials"},{"key":"10.1016\/j.ejpb.2024.114261_b0210","article-title":"Octanol-water Partition coefficients, fundamentals and physical","author":"Sangster","year":"1997","journal-title":"Chemistry"},{"key":"10.1016\/j.ejpb.2024.114261_b0215","article-title":"Logarithmic Partition coefficient Comparison study and Molecular weight of synthesized prodrugs of Ibuprofen+Paracetamol, diclofenac Sodium+Paracetamol and Ibuprofen+Diclofenac sodium, American journal of advanced","volume":"04","author":"Dhrubo Jyoti","year":"2016","journal-title":"Drug Delivery"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124000870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124000870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T11:06:28Z","timestamp":1713179188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124000870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":43,"alternative-id":["S0939641124000870"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114261","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing hydrophobic drug adsorption in an in-vitro extracorporeal membrane oxygenation model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114261"}}